Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: XLB16RJ01B

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Integrin alpha-L/beta-2 (LFA-1) antagonist PubMed PubMed

Cross References

Resources Reference
ChEMBL CHEMBL2109224
FDA SRS XLB16RJ01B